In Study, Drug Flips the Switch on Glioblastoma Multiforme Gene

A research team at Northwestern University has delivered a drug that shuts down a critical gene in glioblastoma multiforme, the incurable brain cancer that kills nearly 13,000 Americans each year. The therapy is based on nanotechnology, and is small enough to get across the blood-brain barrier and to the brain tumor. The drug turns off the gene and proteins that keep cancer cells alive. In a mouse-model study, the drug was injected intravenously, and the survival rate saw a 20 percent increase. The size of the tumor also reduced. Click here to read the details of the study.